Mass Spectrometry Analysis of Nucleic Acid Modifications: From Beginning to Future
Mass Spectrometry Reviews · 2026-07 · 45 (4) · 624-643
DOI: 10.1002/mas.21907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 22.09.2024. Verfasst von Yixuan Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences and Institutes of …. Hauptthemen laut MEDLINE: Mass Spectrometry, Nucleic Acids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Nucleic acids are fundamental biological molecules that encode and convey genetic information within living organisms. Over 150 modifications have been found in nucleic acids, which are involved in critical biological functions, including regulating gene expression, stabilizing nucleic acid structure, modulating protein translation, and so on. The dysregulation of nucleic acid modifications is correlated with many diseases such as cancers and neurological disorders. However, it is still challenging to simultaneously characterize and quantify diverse modifications using traditional genomic methods. Mass spectrometry (MS) has served as a crucial tool to solve this issue, and can directly identify the modified species through their distinct mass differences compared to the canonical ones and provide accurate quantitative information. This review surveys the history of nucleic acid modification discovery, advancements in MS‐based methods, nucleic acid sample preparation, and applications in biological and medical research. We expect the high‐throughput and valuable quantitative information from MS analysis will be more broadly applied to studying nucleic acid modification status in different pathological conditions, which is key to filling gaps in traditional genomics and transcriptomics research and enabling researchers to gain insights into epigenetics and epitranscriptomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Engineering, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Zongtao Lin, Benjamin A Garcia
Förderung
- NICHD NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- Financial support for this work is provided by the National Institutes of Health (AI118891, CA196539, and AG031862) to B.A.G. Z.L. thanks the WUSM BMB Seed Gra…
- Foundation for the National Institutes of Health
Zitieren
APA
Xie, Y., Brás-Costa, C., Lin, Z., & Garcia, B. A. (2026). Mass Spectrometry Analysis of Nucleic Acid Modifications: From Beginning to Future. Mass Spectrometry Reviews, 45(4), 624-643. https://doi.org/10.1002/mas.21907
Vancouver
Xie Y, Brás-Costa C, Lin Z, Garcia BA. Mass Spectrometry Analysis of Nucleic Acid Modifications: From Beginning to Future. Mass Spectrometry Reviews. 2026;45(4):624-643. doi:10.1002/mas.21907
BibTeX
@article{Xie2026,
author = {Xie, Yixuan and Brás-Costa, Carolina and Lin, Zongtao and Garcia, Benjamin A},
title = {Mass Spectrometry Analysis of Nucleic Acid Modifications: From Beginning to Future},
journal = {Mass Spectrometry Reviews},
year = {2026},
volume = {45},
number = {4},
pages = {624--643},
doi = {10.1002/mas.21907}
}
EUVIMED